Respiratory viral infections today, heart failure tomorrow: implications for prevention

The intersection between infectious diseases and cardiovascular outcomes has never been more pressing than in the post-COVID-19 pandemic era.Respiratory viral infections (RVIs)including influenza, SARS-CoV-2, and respiratory syncytial virus (RSV)-are increasingly recognized for their acute respiratory manifestations potentially leading to acute cardiovascular (CV) decompensations and systemic, particularly CV, sequelae.In their recent contribution to the European Journal of Preventive Cardiology, Wee et al. present compelling data quantifying the